Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as ...
GLP-1 weight loss drugs may increase erectile dysfunction risk in men with Type 2 diabetes, but experts say evidence is ...
Add Yahoo as a preferred source to see more of our stories on Google. recreational use of viagra and cialis It’s a big problem — and it’s growing even bigger. Social media users are being bombarded ...
(CNN) — For erectile dysfunction in men with cardiovascular disease, the ED drug phosphodiesterase-5 inhibitors — also known as PDE5i — is a common treatment. But in a new study of more than 60,000 ...
For men with a history of myocardial infarction or PCI, it may be risky to use nitrates for angina and phosphodiesterase-5 (PDE5) inhibitors for erectile dysfunction at the same time, a large Swedish ...
3don MSN
Is erectile dysfunction a side effect of taking weight-loss drugs? New trial results say yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 ...
Please provide your email address to receive an email when new articles are posted on . Men with CAD who combined nitrates with common ED drugs were at higher risk for death and adverse CV events. The ...
The inability to get and maintain an erection is known as erectile dysfunction. It impacts millions of men across the globe. We discuss how treatments are changing with the help of companies such as ...
Erectile dysfunction drugs may be linked with a lower risk for developing Alzheimer’s disease, but researchers want to see more studies on the association, a study published yesterday in Neurology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results